You are here

Researchers study the care experience of patients receiving opioid treatment at Crosstown Clinic

Everybody wants a health care provider that they can trust; someone that they can talk to, who respects them, and who wants them to have the care that works best for their needs. The same is true for people who receive injectable opioid agonist treatment (iOAT) for opioid use disorder, according to new research led by Kirsten Marchand, a trainee at the Centre for Health Evaluation and Outcome Sciences (CHÉOS).

Marchand, who is a PhD candidate at the School of Population and Public Health at UBC, explored the experiences of patients at Crosstown Clinic, which was the first iOAT program in North America.

The research team was interested in understanding clients’ experiences in the iOAT program and whether they felt that the care was patient-centered.

“Patient-centered care is the idea that care should be personalized, respectful, and empowering,” she explained.

Read the full story on The Daily Scan